RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,498,398 | -53.7% | 891,605 | -30.9% | 0.00% | -33.3% |
| Q2 2023 | $16,195,504 | -29.7% | 1,289,451 | -7.8% | 0.00% | -40.0% |
| Q1 2023 | $23,043,161 | +21.1% | 1,399,099 | +9.9% | 0.01% | +25.0% |
| Q4 2022 | $19,024,821 | -40.4% | 1,273,415 | -10.7% | 0.00% | -42.9% |
| Q3 2022 | $31,906,000 | +98.5% | 1,426,303 | +48.6% | 0.01% | +75.0% |
| Q2 2022 | $16,076,000 | +78.6% | 959,783 | +219.1% | 0.00% | +100.0% |
| Q1 2022 | $9,002,000 | -33.8% | 300,771 | -32.1% | 0.00% | -33.3% |
| Q4 2021 | $13,604,000 | +170.3% | 443,001 | +177.6% | 0.00% | +200.0% |
| Q3 2021 | $5,032,000 | -30.1% | 159,581 | -18.9% | 0.00% | -50.0% |
| Q2 2021 | $7,198,000 | -78.5% | 196,738 | -79.6% | 0.00% | -75.0% |
| Q1 2021 | $33,402,000 | +16.6% | 966,200 | +40.2% | 0.01% | +14.3% |
| Q4 2020 | $28,644,000 | +532.3% | 689,214 | +548.0% | 0.01% | +600.0% |
| Q3 2020 | $4,530,000 | – | 106,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |